VIAF

Virtual International Authority File

Search

Leader 00000nz a2200037n 45 0
001 WKP|Q42670259 (VIAF cluster) (Authority/Source Record)
003 WKP
005 20241120235816.0
008 241120nneanz||abbn n and d
035 ‎‡a (WKP)Q42670259‏
024 ‎‡a 0000-0001-6093-0726‏ ‎‡2 orcid‏
035 ‎‡a (OCoLC)Q42670259‏
100 0 ‎‡a Zhi-hong Liu‏ ‎‡9 sl‏
400 0 ‎‡a Zhi-hong Liu‏ ‎‡c researcher‏ ‎‡9 en‏
400 0 ‎‡a Zhi-hong Liu‏ ‎‡c wetenschapper‏ ‎‡9 nl‏
400 0 ‎‡a Zhi-hong Liu‏ ‎‡c investigador/a‏ ‎‡9 es‏
400 0 ‎‡a Zhi-hong Liu‏ ‎‡c investigador‏ ‎‡9 ast‏
670 ‎‡a Author's A complete genomic analysis of the apolipoprotein E gene in Chinese patients with lipoprotein glomerulopathy.‏
670 ‎‡a Author's A non-invasive laboratory panel as a diagnostic and prognostic biomarker for thrombotic microangiopathy: development and application in a Chinese cohort study‏
670 ‎‡a Author's A risk stratification for systemic immunoglobulin light-chain amyloidosis with renal involvement‏
670 ‎‡a Author's A unique case of γ-heavy chain deposition disease characterized by concomitant deposition of γ2 and γ4 subclasses‏
670 ‎‡a Author's ACE-inhibition increases podocyte number in experimental glomerular disease independent of proliferation‏
670 ‎‡a Author's Acute Kidney Injury in Pregnancy: The Need for Higher Awareness. A Pragmatic Review Focused on What Could Be Improved in the Prevention and Care of Pregnancy-Related AKI, in the Year Dedicated to Women and Kidney Diseases‏
670 ‎‡a Author's Acute lymphoblastic leukemia complicated by acute renal failure: a case report and review of the literature.‏
670 ‎‡a Author's Amylin deposition in the kidney of patients with diabetic nephropathy‏
670 ‎‡a Author's An elevated percentage of reticulated platelet is associated with increased mortality in septic shock patients.‏
670 ‎‡a Author's Antineutrophil cytoplasmic antibodies (ANCA) in Chinese patients with anti-GBM crescentic glomerulonephritis‏
670 ‎‡a Author's artikull shkencor i botuar në vitin 2022‏
670 ‎‡a Author's Assessment of urinary kidney injury molecule-1 and interleukin-18 in the early post-burn period to predict acute kidney injury for various degrees of burn injury.‏
670 ‎‡a Author's Association of interleukin-10 gene -592 A/C polymorphism with the clinical and pathological diversity of lupus nephritis.‏
670 ‎‡a Author's BK Virus-Associated Nephropathy with Plasma Cell-Rich Infiltrates Treated by Bortezomib-Based Regimen.‏
670 ‎‡a Author's Capillary dilation and rarefaction are correlated with intracapillary inflammation in antibody-mediated rejection.‏
670 ‎‡a Author's Cardiac troponin I is abnormally expressed in non-small cell lung cancer tissues and human cancer cells‏
670 ‎‡a Author's CD47 deficiency ameliorates autoimmune nephritis in Fas(lpr) mice by suppressing IgG autoantibody production‏
670 ‎‡a Author's Challenge in pathologic diagnosis of Alport syndrome: evidence from correction of previous misdiagnosis‏
670 ‎‡a Author's Chronic Kidney Disease in Patients With Lacunar Stroke: Association With Enlarged Perivascular Spaces and Total Magnetic Resonance Imaging Burden of Cerebral Small Vessel Disease‏
670 ‎‡a Author's Circulating anti-endothelial cell antibodies are associated with poor outcome in renal allograft recipients with acute rejection‏
670 ‎‡a Author's Circulating Mitochondrial DAMPs Are Not Effective Inducers of Proteinuria and Kidney Injury in Rodents‏
670 ‎‡a Author's Class V lupus nephritis: a clinicopathologic study in 152 patients‏
670 ‎‡a Author's Clearance of myoglobin by high cutoff continuous veno-venous hemodialysis in a patient with rhabdomyolysis: a case report‏
670 ‎‡a Author's Clinical and morphological features of collagen type III glomerulopathy: a report of nine cases from a single institution.‏
670 ‎‡a Author's Clinical and morphological features of fibronectin glomerulopathy: a report of ten patients from a single institution.‏
670 ‎‡a Author's Clinical and pathological features of dense deposit disease in Chinese patients.‏
670 ‎‡a Author's Clinical and pathological spectrums of aristolochic acid nephropathy‏
670 ‎‡a Author's Clinical features and renal outcome in lupus patients with diffuse crescentic glomerulonephritis‏
670 ‎‡a Author's Clinicopathological and genetic characteristics in Chinese patients with lipoprotein glomerulopathy.‏
670 ‎‡a Author's Clinicopathological features and prognosis of Chinese patients with acute post-streptococcal glomerulonephritis‏
670 ‎‡a Author's Coexistence of Fabry disease and IgA nephropathy: a report of two cases‏
670 ‎‡a Author's Comparison of double filtration plasmapheresis with immunoadsorption therapy in patients with anti-glomerular basement membrane nephritis‏
670 ‎‡a Author's Comparison of Glomerular and Podocyte mRNA Profiles in Streptozotocin-Induced Diabetes‏
670 ‎‡a Author's Complement induces podocyte pyroptosis in membranous nephropathy by mediating mitochondrial dysfunction‏
670 ‎‡a Author's Confirmation and prevention of intestinal barrier dysfunction and bacterial translocation caused by methotrexate‏
670 ‎‡a Author's Corticosteroid therapy in IgA nephropathy with minimal change-like lesions: a single-centre cohort study‏
670 ‎‡a Author's D-dimer as an early marker of severity in patients with acute superior mesenteric venous thrombosis‏
670 ‎‡a Author's De novo development of circulating anti-endothelial cell antibodies rather than pre-existing antibodies is associated with post-transplant allograft rejection‏
670 ‎‡a Author's De novo expression of podocyte proteins in parietal epithelial cells in experimental aging nephropathy‏
670 ‎‡a Author's Decreased platelet count in patients receiving continuous veno-venous hemofiltration: a single-center retrospective study‏
670 ‎‡a Author's Delayed renal function recovery from drug-induced acute interstitial nephritis‏
670 ‎‡a Author's Delivery of therapeutic radioisotopes using nanoparticle platforms: potential benefit in systemic radiation therapy‏
670 ‎‡a Author's Detectable circulating antiendothelial cell antibodies in renal allograft recipients with C4d-positive acute rejection: a report of three cases‏
670 ‎‡a Author's Detection of anti-PLA2R autoantibodies and IgG subclasses in post-allogeneic hematopoietic stem cell transplantation membranous nephropathy‏
670 ‎‡a Author's Diagnosis, pathogenesis, treatment, and prognosis of hereditary fibrinogen A alpha-chain amyloidosis‏
670 ‎‡a Author's Dissection of Glomerular Transcriptional Profile in Patients with Diabetic Nephropathy: SRGAP2a Protects Podocyte Structure and Function‏
670 ‎‡a Author's Downregulation of microRNA-30 facilitates podocyte injury and is prevented by glucocorticoids‏
670 ‎‡a Author's Effect of equivalent doses of fentanyl, sufentanil, and remifentanil on the incidence and severity of cough in patients undergoing abdominal surgery: A prospective, randomized, double-blind study.‏
670 ‎‡a Author's Effectiveness of renin–angiotensin–aldosterone system blockers in patients with Alport syndrome: a systematic review and meta-analysis‏
670 ‎‡a Author's Endothelial injury in transplant glomerulopathy is correlated with transcription factor T-bet expression.‏
670 ‎‡a Author's Enhanced expression of ANGPTL2 in the microvascular lesions of diabetic glomerulopathy‏
670 ‎‡a Author's Epidemiologic data of renal diseases from a single unit in China: analysis based on 13,519 renal biopsies‏
670 ‎‡a Author's Epistatic effect of plasminogen activator inhibitor 1 and beta-fibrinogen genes on risk of glomerular microthrombosis in lupus nephritis: interaction with environmental/clinical factors‏
670 ‎‡a Author's Etiology and Outcome of Crescentic Glomerulonephritis From a Single Center in China: A 10-Year Review.‏
670 ‎‡a Author's Evaluation of metabolic risk marker in obesity-related glomerulopathy‏
670 ‎‡a Author's Evaluation of podocyte lesion in patients with diabetic nephropathy: Wilms' tumor-1 protein used as a podocyte marker‏
670 ‎‡a Author's Evaluation of renal vascular lesions using circulating endothelial cells in patients with lupus nephritis‏
670 ‎‡a Author's Evaluation of vascular lesions using circulating endothelial cells in renal transplant patients‏
670 ‎‡a Author's Exogenous plant MIR168a specifically targets mammalian LDLRAP1: evidence of cross-kingdom regulation by microRNA‏
670 ‎‡a Author's Expression of the EphA1 protein is associated with Fuhrman nuclear grade in clear cell renal cell carcinomas.‏
670 ‎‡a Author's Fabry disease: renal biopsy-proven cases from China‏
670 ‎‡a Author's Fast track surgery vs. conventional management in the perioperative care of retroperitoneal laparoscopic adrenalectomy‏
670 ‎‡a Author's Fluid overload at start of continuous renal replacement therapy is associated with poorer clinical condition and outcome: a prospective observational study on the combined use of bioimpedance vector analysis and serum N-terminal pro-B-type natriuret‏
670 ‎‡a Author's GADD45B mediates podocyte injury in zebrafish by activating the ROS-GADD45B-p38 pathway‏
670 ‎‡a Author's Gender differences of B cell signature in healthy subjects underlie disparities in incidence and course of SLE related to estrogen.‏
670 ‎‡a Author's Genome-wide screen of DNA methylation changes induced by low dose X-ray radiation in mice.‏
670 ‎‡a Author's Glomerular endothelial cell injury and cross talk in diabetic kidney disease‏
670 ‎‡a Author's Glomerular expression of C-C chemokines in different types of human crescentic glomerulonephritis‏
670 ‎‡a Author's Glucocorticoid receptor wields chromatin interactions to tune transcription for cytoskeleton stabilization in podocytes‏
670 ‎‡a Author's Glucose transporter (GLUT1) allele (XbaI-) associated with nephropathy in non-insulin-dependent diabetes mellitus‏
670 ‎‡a Author's Glycogen synthase kinase 3β dictates podocyte motility and focal adhesion turnover by modulating paxillin activity: implications for the protective effect of low-dose lithium in podocytopathy‏
670 ‎‡a Author's Glycogen synthase kinase 3β orchestrates microtubule remodeling in compensatory glomerular adaptation to podocyte depletion‏
670 ‎‡a Author's Heart-type fatty acid binding protein is associated with proteinuria in obesity‏
670 ‎‡a Author's Identification of glomerular lesions and intrinsic glomerular cells types in kidney diseases via deep learning‏
670 ‎‡a Author's Immunophenotyping in BK virus allograft nephropathy distinct from acute rejection‏
670 ‎‡a Author's Impact of continuous quality improvement initiatives on clinical outcomes in peritoneal dialysis‏
670 ‎‡a Author's [Impact of platelet derived growth factor in the glomeruli of active lupus nephritis]‏
670 ‎‡a Author's Improvement of Outcomes in Patients with Lupus Nephritis: Management Evolution in Chinese Patients from 1994 to 2010‏
670 ‎‡a Author's Increased miR-374b promotes cell proliferation and the production of aberrant glycosylated IgA1 in B cells of IgA nephropathy.‏
670 ‎‡a Author's Induction therapy with bortezomib and dexamethasone followed by autologous stem cell transplantation versus autologous stem cell transplantation alone in the treatment of renal AL amyloidosis: a randomized controlled trial‏
670 ‎‡a Author's Influence of guideline adherence and parameter control on the clinical outcomes in patients with diabetic nephropathy‏
670 ‎‡a Author's Inhibition of glycogen synthase kinase-3β prevents NSAID-induced acute kidney injury.‏
670 ‎‡a Author's Inhibition of miRNA-21 prevents fibrogenic activation in podocytes and tubular cells in IgA nephropathy‏
670 ‎‡a Author's Initial transcatheter thrombolysis for acute superior mesenteric venous thrombosis‏
670 ‎‡a Author's Interleukin-1 receptor antagonist allele: is it a genetic link between Henoch-Schönlein nephritis and IgA nephropathy?‏
670 ‎‡a Author's Late developing C4d-positive humoral renal allograft rejection associated with withdrawal of mycophenolate mofetil‏
670 ‎‡a Author's Lipoprotein glomerulopathy: clinical features and pathological characteristics in Chinese.‏
670 ‎‡a Author's Long-term outcome and prognostic factors of idiopathic membranous nephropathy in the Chinese population‏
670 ‎‡a Author's Long-term outcome of Chinese patients with membranous lupus nephropathy‏
670 ‎‡a Author's Long-term outcome of IgA nephropathy patients with recurrent macroscopic hematuria‏
670 ‎‡a Author's Long-term outcome of IgA nephropathy with minimal change disease: a comparison between patients with and without minimal change disease‏
670 ‎‡a Author's Long-term renal survival and related risk factors in patients with IgA nephropathy: results from a cohort of 1155 cases in a Chinese adult population‏
670 ‎‡a Author's Malignant perivascular epithelioid cell tumor (PEComa) of cervix with TFE3 gene rearrangement: a case report.‏
670 ‎‡a Author's Melatonin, a potent regulator of hemeoxygenase-1, reduces cardiopulmonary bypass-induced renal damage in rats‏
670 ‎‡a Author's Mercury-induced membranous nephropathy: clinical and pathological features‏
670 ‎‡a Author's Mycophenolate mofetil vs cyclophosphamide therapy for patients with diffuse proliferative lupus nephritis.‏
670 ‎‡a Author's Nephrology in china‏
670 ‎‡a Author's Nephrotic proteinuria and hypertension‏
670 ‎‡a Author's NSFC health research funding and burden of disease in China‏
670 ‎‡a Author's Obesity-related glomerulopathy: body mass index and proteinuria‏
670 ‎‡a Author's Obesity-related glomerulopathy in China: a case series of 90 patients‏
670 ‎‡a Author's Obesity-related glomerulopathy: insights from gene expression profiles of the glomeruli derived from renal biopsy samples‏
670 ‎‡a Author's Observation of efficacy and safety of converting the calcineurin inhibitor to sirolimus in renal transplant recipients with chronic allograft nephropathy‏
670 ‎‡a Author's Peritoneal dialysis treatment for severe lupus nephritis patients complicated with essential organ dysfunction‏
670 ‎‡a Author's Peritubular capillary C4d deposition in lupus nephritis different from antibody-mediated renal rejection‏
670 ‎‡a Author's Picking transplant glomerulopathy out of the CAN: evidence from a clinico-pathological evaluation‏
670 ‎‡a Author's Podocyte autophagic activity plays a protective role in renal injury and delays the progression of podocytopathies‏
670 ‎‡a Author's Podocyte lesions in patients with obesity-related glomerulopathy‏
670 ‎‡a Author's Podocyte repopulation by renal progenitor cells following glucocorticoids treatment in experimental FSGS‏
670 ‎‡a Author's Prediction of renal outcomes in patients with crescentic lupus nephritis.‏
670 ‎‡a Author's Predominance of intraglomerular T-bet or GATA3 may determine mechanism of transplant rejection‏
670 ‎‡a Author's Presence of foam cells in kidney interstitium is associated with progression of renal injury in patients with glomerular diseases‏
670 ‎‡a Author's Primary focal segmental glomerulosclerosis in nephrotic patients: common complications and risk factors‏
670 ‎‡a Author's PSF/SFPQ is a very common gene fusion partner in TFE3 rearrangement-associated perivascular epithelioid cell tumors (PEComas) and melanotic Xp11 translocation renal cancers: clinicopathologic, immunohistochemical, and molecular characteristics sugge‏
670 ‎‡a Author's Randomized Controlled Trial to Evaluate Regional Citrate Anticoagulation Plus Low-Dose of Dalteparin in Continuous Veno-Venous Hemofiltration.‏
670 ‎‡a Author's Recurrent or de novo IgA nephropathy with crescent formation after renal transplantation‏
670 ‎‡a Author's Recurrent Proliferative Glomerulonephritis With Monoclonal IgG Deposits After a Renal Transplant Which Was Insensitive to Pulse Therapy Remitted by Double Filtration Plasmapheresis‏
670 ‎‡a Author's Regulation of MUTYH, a DNA Repair Enzyme, in Renal Proximal Tubular Epithelial Cells‏
670 ‎‡a Author's Relationship between serum soluble urokinase plasminogen activator receptor level and steroid responsiveness in FSGS‏
670 ‎‡a Author's Renal biopsy in type 2 diabetes: timing of complications and evaluating of safety in Chinese patients‏
670 ‎‡a Author's Renal histologic changes and the outcome in patients with diabetic nephropathy‏
670 ‎‡a Author's Renal involvement in non-Hodgkin lymphoma: proven by renal biopsy‏
670 ‎‡a Author's Rescue therapy by immunoadsorption in combination with tacrolimus and mycophenolate mofetil for C4d-positive acute humoral renal allograft rejection‏
670 ‎‡a Author's Retinoids augment the expression of podocyte proteins by glomerular parietal epithelial cells in experimental glomerular disease.‏
670 ‎‡a Author's Reversal of active glomerular lesions after immunosuppressive therapy in patients with IgA nephropathy: a repeat-biopsy based observation‏
670 ‎‡a Author's Risk factors of venous thromboembolism in focal segmental glomerulosclerosis with nephrotic syndrome‏
670 ‎‡a Author's Role of Myeloid-Derived Suppressor Cells in Glucocorticoid-Mediated Amelioration of FSGS.‏
670 ‎‡a Author's Roles of mast cells and monocyte chemoattractant protein-1 in the renal injury of obesity-related glomerulopathy‏
670 ‎‡a Author's Sarcopenia in patients undergoing maintenance hemodialysis: incidence rate, risk factors and its effect on survival risk.‏
670 ‎‡a Author's Significance of anti-neutrophil cytoplasmic antibodies in patients with pauci-immune crescentic glomerulonephritis‏
670 ‎‡a Author's Significance of vascular endothelial growth factor expression in renal tissue of patients with preeclamptic nephropathy‏
670 ‎‡a Author's Successful renal transplantation in a patient with antineutrophil cytoplasmic autoantibody-associated microscopic polyangiitis: effect of early plasma exchange and mycophenolate mofetil‏
670 ‎‡a Author's Successful treatment of class V+IV lupus nephritis with multitarget therapy.‏
670 ‎‡a Author's Tacrolimus combined with mycophenolate mofetil can effectively reverse C4d-positive steroid-resistant acute rejection in Chinese renal allograft recipients‏
670 ‎‡a Author's The application of urinary proteomics for the detection of biomarkers of kidney diseases.‏
670 ‎‡a Author's The Association of a Genetic Variant in SCAF8-CNKSR3 with Diabetic Kidney Disease and Diabetic Retinopathy in a Chinese Population.‏
670 ‎‡a Author's The clinical and pathological characteristics of Chinese patients with pauci-immune crescent glomerulonephritis.‏
670 ‎‡a Author's The clinical course and long-term outcome of primary focal segmental glomerulosclerosis in Chinese adults‏
670 ‎‡a Author's The clinical features and outcomes of systemic AL amyloidosis: a cohort of 231 Chinese patients‏
670 ‎‡a Author's The evolution of morphological variants of focal segmental glomerulosclerosis: a repeat biopsy-based observation.‏
670 ‎‡a Author's The prevalence of immunologic injury in renal allograft recipients with de novo proteinuria‏
670 ‎‡a Author's The primary glomerulonephritides: a systems biology approach‏
670 ‎‡a Author's The prognosis of biopsy-proven lupus nephritis in chinese patients: long term follow-up of 86 cases.‏
670 ‎‡a Author's The relationship between body fat distribution and renal damage in Chinese with obesity‏
670 ‎‡a Author's The relationship between obesity and diabetic nephropathy in China‏
670 ‎‡a Author's The spectrum of biopsy-proven kidney diseases in elderly Chinese patients‏
670 ‎‡a Author's Treatment of diabetic nephropathy with Tripterygium wilfordii Hook F extract: a prospective, randomized, controlled clinical trial‏
670 ‎‡a Author's Treatment of early mixed cellular and humoral renal allograft rejection with tacrolimus and mycophenolate mofetil‏
670 ‎‡a Author's [Treatment of severe acute renal failure with continuous renal replacement therapy]‏
670 ‎‡a Author's Tripterygium wilfordii hook f increase the blood concentration of tacrolimus‏
670 ‎‡a Author's Triptolide reduces proteinuria in experimental membranous nephropathy and protects against C5b-9-induced podocyte injury in vitro.‏
670 ‎‡a Author's Types of M protein and clinicopathological profiles in patients with monoclonal gammopathy of renal significance‏
670 ‎‡a Author's Using an isolated rat kidney model to identify kidney origin proteins in urine‏
670 ‎‡a Author's Vascular calcification burden of Chinese patients with chronic kidney disease: methodology of a cohort study‏
909 ‎‡a (orcid) 0000000160930726‏ ‎‡9 1‏
912 ‎‡a artikullshkencor1botuarnevitin‏ ‎‡A artikull shkencor i botuar në vitin 2022‏ ‎‡9 1‏
919 ‎‡a completegenomicanalysisoftheapolipoproteinegeneinchinesepatientswithlipoproteinglomerulopathy‏ ‎‡A A complete genomic analysis of the apolipoprotein E gene in Chinese patients with lipoprotein glomerulopathy.‏ ‎‡9 1‏
919 ‎‡a noninvasivelaboratorypanelasadiagnosticandprognosticbiomarkerforthromboticmicroangiopathydevelopmentandapplicationinachinesecohortstudy‏ ‎‡A A non-invasive laboratory panel as a diagnostic and prognostic biomarker for thrombotic microangiopathy: development and application in a Chinese cohort study‏ ‎‡9 1‏
919 ‎‡a riskstratificationforsystemicimmunoglobulinlightchainamyloidosiswithrenalinvolvement‏ ‎‡A A risk stratification for systemic immunoglobulin light-chain amyloidosis with renal involvement‏ ‎‡9 1‏
919 ‎‡a uniquecaseofγheavychaindepositiondiseasecharacterizedbyconcomitantdepositionofγ2andγ4subclasses‏ ‎‡A A unique case of γ-heavy chain deposition disease characterized by concomitant deposition of γ2 and γ4 subclasses‏ ‎‡9 1‏
919 ‎‡a aceinhibitionincreasespodocytenumberinexperimentalglomerulardiseaseindependentofproliferation‏ ‎‡A ACE-inhibition increases podocyte number in experimental glomerular disease independent of proliferation‏ ‎‡9 1‏
919 ‎‡a acutekidneyinjuryinpregnancytheneedforhigherawarenessapragmaticreviewfocusedonwhatcouldbeimprovedinthepreventionandcareofpregnancyrelatedakiintheyeardedicatedtowomenandkidneydiseases‏ ‎‡A Acute Kidney Injury in Pregnancy: The Need for Higher Awareness. A Pragmatic Review Focused on What Could Be Improved in the Prevention and Care of Pregnancy-Related AKI, in the Year Dedicated to Women and Kidney Diseases‏ ‎‡9 1‏
919 ‎‡a acutelymphoblasticleukemiacomplicatedbyacuterenalfailureacasereportandreviewoftheliterature‏ ‎‡A Acute lymphoblastic leukemia complicated by acute renal failure: a case report and review of the literature.‏ ‎‡9 1‏
919 ‎‡a amylindepositioninthekidneyofpatientswithdiabeticnephropathy‏ ‎‡A Amylin deposition in the kidney of patients with diabetic nephropathy‏ ‎‡9 1‏
919 ‎‡a elevatedpercentageofreticulatedplateletisassociatedwithincreasedmortalityinsepticshockpatients‏ ‎‡A An elevated percentage of reticulated platelet is associated with increased mortality in septic shock patients.‏ ‎‡9 1‏
919 ‎‡a antineutrophilcytoplasmicantibodiesancainchinesepatientswithantigbmcrescenticglomerulonephritis‏ ‎‡A Antineutrophil cytoplasmic antibodies (ANCA) in Chinese patients with anti-GBM crescentic glomerulonephritis‏ ‎‡9 1‏
919 ‎‡a assessmentofurinarykidneyinjurymolecule1andinterleukin18intheearlypostburnperiodtopredictacutekidneyinjuryforvariousdegreesofburninjury‏ ‎‡A Assessment of urinary kidney injury molecule-1 and interleukin-18 in the early post-burn period to predict acute kidney injury for various degrees of burn injury.‏ ‎‡9 1‏
919 ‎‡a associationofinterleukin10gene592a100polymorphismwiththeclinicalandpathologicaldiversityoflupusnephritis‏ ‎‡A Association of interleukin-10 gene -592 A/C polymorphism with the clinical and pathological diversity of lupus nephritis.‏ ‎‡9 1‏
919 ‎‡a bkvirusassociatednephropathywithplasmacellrichinfiltratestreatedbybortezomibbasedregimen‏ ‎‡A BK Virus-Associated Nephropathy with Plasma Cell-Rich Infiltrates Treated by Bortezomib-Based Regimen.‏ ‎‡9 1‏
919 ‎‡a capillarydilationandrarefactionarecorrelatedwithintracapillaryinflammationinantibodymediatedrejection‏ ‎‡A Capillary dilation and rarefaction are correlated with intracapillary inflammation in antibody-mediated rejection.‏ ‎‡9 1‏
919 ‎‡a cardiactroponin1isabnormallyexpressedinnonsmallcelllungcancertissuesandhumancancercells‏ ‎‡A Cardiac troponin I is abnormally expressed in non-small cell lung cancer tissues and human cancer cells‏ ‎‡9 1‏
919 ‎‡a cd47deficiencyamelioratesautoimmunenephritisinfaslprmicebysuppressingiggautoantibodyproduction‏ ‎‡A CD47 deficiency ameliorates autoimmune nephritis in Fas(lpr) mice by suppressing IgG autoantibody production‏ ‎‡9 1‏
919 ‎‡a challengeinpathologicdiagnosisofalportsyndromeevidencefromcorrectionofpreviousmisdiagnosis‏ ‎‡A Challenge in pathologic diagnosis of Alport syndrome: evidence from correction of previous misdiagnosis‏ ‎‡9 1‏
919 ‎‡a chronickidneydiseaseinpatientswithlacunarstrokeassociationwithenlargedperivascularspacesandtotalmagneticresonanceimagingburdenofcerebralsmallvesseldisease‏ ‎‡A Chronic Kidney Disease in Patients With Lacunar Stroke: Association With Enlarged Perivascular Spaces and Total Magnetic Resonance Imaging Burden of Cerebral Small Vessel Disease‏ ‎‡9 1‏
919 ‎‡a circulatingantiendothelialcellantibodiesareassociatedwithpooroutcomeinrenalallograftrecipientswithacuterejection‏ ‎‡A Circulating anti-endothelial cell antibodies are associated with poor outcome in renal allograft recipients with acute rejection‏ ‎‡9 1‏
919 ‎‡a circulatingmitochondrialdampsarenoteffectiveinducersofproteinuriaandkidneyinjuryinrodents‏ ‎‡A Circulating Mitochondrial DAMPs Are Not Effective Inducers of Proteinuria and Kidney Injury in Rodents‏ ‎‡9 1‏
919 ‎‡a class5lupusnephritisaclinicopathologicstudyin152patients‏ ‎‡A Class V lupus nephritis: a clinicopathologic study in 152 patients‏ ‎‡9 1‏
919 ‎‡a clearanceofmyoglobinbyhighcutoffcontinuousvenovenoushemodialysisinapatientwithrhabdomyolysisacasereport‏ ‎‡A Clearance of myoglobin by high cutoff continuous veno-venous hemodialysis in a patient with rhabdomyolysis: a case report‏ ‎‡9 1‏
919 ‎‡a clinicalandmorphologicalfeaturesofcollagentype3glomerulopathyareportof9casesfromasingleinstitution‏ ‎‡A Clinical and morphological features of collagen type III glomerulopathy: a report of nine cases from a single institution.‏ ‎‡9 1‏
919 ‎‡a clinicalandmorphologicalfeaturesoffibronectinglomerulopathyareportof10patientsfromasingleinstitution‏ ‎‡A Clinical and morphological features of fibronectin glomerulopathy: a report of ten patients from a single institution.‏ ‎‡9 1‏
919 ‎‡a clinicalandpathologicalfeaturesofdensedepositdiseaseinchinesepatients‏ ‎‡A Clinical and pathological features of dense deposit disease in Chinese patients.‏ ‎‡9 1‏
919 ‎‡a clinicalandpathologicalspectrumsofaristolochicacidnephropathy‏ ‎‡A Clinical and pathological spectrums of aristolochic acid nephropathy‏ ‎‡9 1‏
919 ‎‡a clinicalfeaturesandrenaloutcomeinlupuspatientswithdiffusecrescenticglomerulonephritis‏ ‎‡A Clinical features and renal outcome in lupus patients with diffuse crescentic glomerulonephritis‏ ‎‡9 1‏
919 ‎‡a clinicopathologicalandgeneticcharacteristicsinchinesepatientswithlipoproteinglomerulopathy‏ ‎‡A Clinicopathological and genetic characteristics in Chinese patients with lipoprotein glomerulopathy.‏ ‎‡9 1‏
919 ‎‡a clinicopathologicalfeaturesandprognosisofchinesepatientswithacutepoststreptococcalglomerulonephritis‏ ‎‡A Clinicopathological features and prognosis of Chinese patients with acute post-streptococcal glomerulonephritis‏ ‎‡9 1‏
919 ‎‡a coexistenceoffabrydiseaseandiganephropathyareportof2cases‏ ‎‡A Coexistence of Fabry disease and IgA nephropathy: a report of two cases‏ ‎‡9 1‏
919 ‎‡a comparisonofdoublefiltrationplasmapheresiswithimmunoadsorptiontherapyinpatientswithantiglomerularbasementmembranenephritis‏ ‎‡A Comparison of double filtration plasmapheresis with immunoadsorption therapy in patients with anti-glomerular basement membrane nephritis‏ ‎‡9 1‏
919 ‎‡a comparisonofglomerularandpodocytemrnaprofilesinstreptozotocininduceddiabetes‏ ‎‡A Comparison of Glomerular and Podocyte mRNA Profiles in Streptozotocin-Induced Diabetes‏ ‎‡9 1‏
919 ‎‡a complementinducespodocytepyroptosisinmembranousnephropathybymediatingmitochondrialdysfunction‏ ‎‡A Complement induces podocyte pyroptosis in membranous nephropathy by mediating mitochondrial dysfunction‏ ‎‡9 1‏
919 ‎‡a confirmationandpreventionofintestinalbarrierdysfunctionandbacterialtranslocationcausedbymethotrexate‏ ‎‡A Confirmation and prevention of intestinal barrier dysfunction and bacterial translocation caused by methotrexate‏ ‎‡9 1‏
919 ‎‡a corticosteroidtherapyiniganephropathywithminimalchangelikelesionsasinglecentrecohortstudy‏ ‎‡A Corticosteroid therapy in IgA nephropathy with minimal change-like lesions: a single-centre cohort study‏ ‎‡9 1‏
919 ‎‡a 500dimerasanearlymarkerofseverityinpatientswithacutesuperiormesentericvenousthrombosis‏ ‎‡A D-dimer as an early marker of severity in patients with acute superior mesenteric venous thrombosis‏ ‎‡9 1‏
919 ‎‡a novodevelopmentofcirculatingantiendothelialcellantibodiesratherthanpreexistingantibodiesisassociatedwithposttransplantallograftrejection‏ ‎‡A De novo development of circulating anti-endothelial cell antibodies rather than pre-existing antibodies is associated with post-transplant allograft rejection‏ ‎‡9 1‏
919 ‎‡a novoexpressionofpodocyteproteinsinparietalepithelialcellsinexperimentalagingnephropathy‏ ‎‡A De novo expression of podocyte proteins in parietal epithelial cells in experimental aging nephropathy‏ ‎‡9 1‏
919 ‎‡a decreasedplateletcountinpatientsreceivingcontinuousvenovenoushemofiltrationasinglecenterretrospectivestudy‏ ‎‡A Decreased platelet count in patients receiving continuous veno-venous hemofiltration: a single-center retrospective study‏ ‎‡9 1‏
919 ‎‡a delayedrenalfunctionrecoveryfromdruginducedacuteinterstitialnephritis‏ ‎‡A Delayed renal function recovery from drug-induced acute interstitial nephritis‏ ‎‡9 1‏
919 ‎‡a deliveryoftherapeuticradioisotopesusingnanoparticleplatformspotentialbenefitinsystemicradiationtherapy‏ ‎‡A Delivery of therapeutic radioisotopes using nanoparticle platforms: potential benefit in systemic radiation therapy‏ ‎‡9 1‏
919 ‎‡a detectablecirculatingantiendothelialcellantibodiesinrenalallograftrecipientswithc4dpositiveacuterejectionareportof3cases‏ ‎‡A Detectable circulating antiendothelial cell antibodies in renal allograft recipients with C4d-positive acute rejection: a report of three cases‏ ‎‡9 1‏
919 ‎‡a detectionofantipla2rautoantibodiesandiggsubclassesinpostallogeneichematopoieticstemcelltransplantationmembranousnephropathy‏ ‎‡A Detection of anti-PLA2R autoantibodies and IgG subclasses in post-allogeneic hematopoietic stem cell transplantation membranous nephropathy‏ ‎‡9 1‏
919 ‎‡a diagnosispathogenesistreatmentandprognosisofhereditaryfibrinogenaalphachainamyloidosis‏ ‎‡A Diagnosis, pathogenesis, treatment, and prognosis of hereditary fibrinogen A alpha-chain amyloidosis‏ ‎‡9 1‏
919 ‎‡a dissectionofglomerulartranscriptionalprofileinpatientswithdiabeticnephropathysrgap2aprotectspodocytestructureandfunction‏ ‎‡A Dissection of Glomerular Transcriptional Profile in Patients with Diabetic Nephropathy: SRGAP2a Protects Podocyte Structure and Function‏ ‎‡9 1‏
919 ‎‡a downregulationofmicrorna30facilitatespodocyteinjuryandispreventedbyglucocorticoids‏ ‎‡A Downregulation of microRNA-30 facilitates podocyte injury and is prevented by glucocorticoids‏ ‎‡9 1‏
919 ‎‡a effectofequivalentdosesoffentanylsufentanilandremifentanilontheincidenceandseverityofcoughinpatientsundergoingabdominalsurgeryaprospectiverandomizeddoubleblindstudy‏ ‎‡A Effect of equivalent doses of fentanyl, sufentanil, and remifentanil on the incidence and severity of cough in patients undergoing abdominal surgery: A prospective, randomized, double-blind study.‏ ‎‡9 1‏
919 ‎‡a effectivenessofreninangiotensinaldosteronesystemblockersinpatientswithalportsyndromeasystematicreviewandmetaanalysis‏ ‎‡A Effectiveness of renin–angiotensin–aldosterone system blockers in patients with Alport syndrome: a systematic review and meta-analysis‏ ‎‡9 1‏
919 ‎‡a endothelialinjuryintransplantglomerulopathyiscorrelatedwithtranscriptionfactortbetexpression‏ ‎‡A Endothelial injury in transplant glomerulopathy is correlated with transcription factor T-bet expression.‏ ‎‡9 1‏
919 ‎‡a enhancedexpressionofangptl2inthemicrovascularlesionsofdiabeticglomerulopathy‏ ‎‡A Enhanced expression of ANGPTL2 in the microvascular lesions of diabetic glomerulopathy‏ ‎‡9 1‏
919 ‎‡a epidemiologicdataofrenaldiseasesfromasingleunitinchinaanalysisbasedon13519renalbiopsies‏ ‎‡A Epidemiologic data of renal diseases from a single unit in China: analysis based on 13,519 renal biopsies‏ ‎‡9 1‏
919 ‎‡a epistaticeffectofplasminogenactivatorinhibitor1andbetafibrinogengenesonriskofglomerularmicrothrombosisinlupusnephritisinteractionwithenvironmentalclinicalfactors‏ ‎‡A Epistatic effect of plasminogen activator inhibitor 1 and beta-fibrinogen genes on risk of glomerular microthrombosis in lupus nephritis: interaction with environmental/clinical factors‏ ‎‡9 1‏
919 ‎‡a etiologyandoutcomeofcrescenticglomerulonephritisfromasinglecenterinchinaa10yearreview‏ ‎‡A Etiology and Outcome of Crescentic Glomerulonephritis From a Single Center in China: A 10-Year Review.‏ ‎‡9 1‏
919 ‎‡a evaluationofmetabolicriskmarkerinobesityrelatedglomerulopathy‏ ‎‡A Evaluation of metabolic risk marker in obesity-related glomerulopathy‏ ‎‡9 1‏
919 ‎‡a evaluationofpodocytelesioninpatientswithdiabeticnephropathywilmstumor1proteinusedasapodocytemarker‏ ‎‡A Evaluation of podocyte lesion in patients with diabetic nephropathy: Wilms' tumor-1 protein used as a podocyte marker‏ ‎‡9 1‏
919 ‎‡a evaluationofrenalvascularlesionsusingcirculatingendothelialcellsinpatientswithlupusnephritis‏ ‎‡A Evaluation of renal vascular lesions using circulating endothelial cells in patients with lupus nephritis‏ ‎‡9 1‏
919 ‎‡a evaluationofvascularlesionsusingcirculatingendothelialcellsinrenaltransplantpatients‏ ‎‡A Evaluation of vascular lesions using circulating endothelial cells in renal transplant patients‏ ‎‡9 1‏
919 ‎‡a exogenousplantmir168aspecificallytargetsmammalianldlrap1evidenceofcrosskingdomregulationbymicrorna‏ ‎‡A Exogenous plant MIR168a specifically targets mammalian LDLRAP1: evidence of cross-kingdom regulation by microRNA‏ ‎‡9 1‏
919 ‎‡a expressionoftheepha1proteinisassociatedwithfuhrmannucleargradeinclearcellrenalcellcarcinomas‏ ‎‡A Expression of the EphA1 protein is associated with Fuhrman nuclear grade in clear cell renal cell carcinomas.‏ ‎‡9 1‏
919 ‎‡a fabrydiseaserenalbiopsyprovencasesfromchina‏ ‎‡A Fabry disease: renal biopsy-proven cases from China‏ ‎‡9 1‏
919 ‎‡a fasttracksurgeryvsconventionalmanagementintheperioperativecareofretroperitoneallaparoscopicadrenalectomy‏ ‎‡A Fast track surgery vs. conventional management in the perioperative care of retroperitoneal laparoscopic adrenalectomy‏ ‎‡9 1‏
919 ‎‡a fluidoverloadatstartofcontinuousrenalreplacementtherapyisassociatedwithpoorerclinicalconditionandoutcomeaprospectiveobservationalstudyonthecombineduseofbioimpedancevectoranalysisandserumnterminalprobtypenatriuret‏ ‎‡A Fluid overload at start of continuous renal replacement therapy is associated with poorer clinical condition and outcome: a prospective observational study on the combined use of bioimpedance vector analysis and serum N-terminal pro-B-type natriuret‏ ‎‡9 1‏
919 ‎‡a gadd45bmediatespodocyteinjuryinzebrafishbyactivatingtherosgadd45bp38pathway‏ ‎‡A GADD45B mediates podocyte injury in zebrafish by activating the ROS-GADD45B-p38 pathway‏ ‎‡9 1‏
919 ‎‡a genderdifferencesofbcellsignatureinhealthysubjectsunderliedisparitiesinincidenceandcourseofslerelatedtoestrogen‏ ‎‡A Gender differences of B cell signature in healthy subjects underlie disparities in incidence and course of SLE related to estrogen.‏ ‎‡9 1‏
919 ‎‡a genomewidescreenofdnamethylationchangesinducedbylowdose10rayradiationinmice‏ ‎‡A Genome-wide screen of DNA methylation changes induced by low dose X-ray radiation in mice.‏ ‎‡9 1‏
919 ‎‡a glomerularendothelialcellinjuryandcrosstalkindiabetickidneydisease‏ ‎‡A Glomerular endothelial cell injury and cross talk in diabetic kidney disease‏ ‎‡9 1‏
919 ‎‡a glomerularexpressionof100100chemokinesindifferenttypesofhumancrescenticglomerulonephritis‏ ‎‡A Glomerular expression of C-C chemokines in different types of human crescentic glomerulonephritis‏ ‎‡9 1‏
919 ‎‡a glucocorticoidreceptorwieldschromatininteractionstotunetranscriptionforcytoskeletonstabilizationinpodocytes‏ ‎‡A Glucocorticoid receptor wields chromatin interactions to tune transcription for cytoskeleton stabilization in podocytes‏ ‎‡9 1‏
919 ‎‡a glucosetransporterglut1allelexbaiassociatedwithnephropathyinnoninsulindependentdiabetesmellitus‏ ‎‡A Glucose transporter (GLUT1) allele (XbaI-) associated with nephropathy in non-insulin-dependent diabetes mellitus‏ ‎‡9 1‏
919 ‎‡a glycogensynthasekinase3βdictatespodocytemotilityandfocaladhesionturnoverbymodulatingpaxillinactivityimplicationsfortheprotectiveeffectoflowdoselithiuminpodocytopathy‏ ‎‡A Glycogen synthase kinase 3β dictates podocyte motility and focal adhesion turnover by modulating paxillin activity: implications for the protective effect of low-dose lithium in podocytopathy‏ ‎‡9 1‏
919 ‎‡a glycogensynthasekinase3βorchestratesmicrotubuleremodelingincompensatoryglomerularadaptationtopodocytedepletion‏ ‎‡A Glycogen synthase kinase 3β orchestrates microtubule remodeling in compensatory glomerular adaptation to podocyte depletion‏ ‎‡9 1‏
919 ‎‡a hearttypefattyacidbindingproteinisassociatedwithproteinuriainobesity‏ ‎‡A Heart-type fatty acid binding protein is associated with proteinuria in obesity‏ ‎‡9 1‏
919 ‎‡a identificationofglomerularlesionsandintrinsicglomerularcellstypesinkidneydiseasesviadeeplearning‏ ‎‡A Identification of glomerular lesions and intrinsic glomerular cells types in kidney diseases via deep learning‏ ‎‡9 1‏
919 ‎‡a immunophenotypinginbkvirusallograftnephropathydistinctfromacuterejection‏ ‎‡A Immunophenotyping in BK virus allograft nephropathy distinct from acute rejection‏ ‎‡9 1‏
919 ‎‡a impactofcontinuousqualityimprovementinitiativesonclinicaloutcomesinperitonealdialysis‏ ‎‡A Impact of continuous quality improvement initiatives on clinical outcomes in peritoneal dialysis‏ ‎‡9 1‏
919 ‎‡a impactofplateletderivedgrowthfactorintheglomeruliofactivelupusnephritis‏ ‎‡A [Impact of platelet derived growth factor in the glomeruli of active lupus nephritis]‏ ‎‡9 1‏
919 ‎‡a improvementofoutcomesinpatientswithlupusnephritismanagementevolutioninchinesepatientsfrom1994to‏ ‎‡A Improvement of Outcomes in Patients with Lupus Nephritis: Management Evolution in Chinese Patients from 1994 to 2010‏ ‎‡9 1‏
919 ‎‡a increasedmir374bpromotescellproliferationandtheproductionofaberrantglycosylatediga1inbcellsofiganephropathy‏ ‎‡A Increased miR-374b promotes cell proliferation and the production of aberrant glycosylated IgA1 in B cells of IgA nephropathy.‏ ‎‡9 1‏
919 ‎‡a inductiontherapywithbortezomibanddexamethasonefollowedbyautologousstemcelltransplantationversusautologousstemcelltransplantationaloneinthetreatmentofrenalalamyloidosisarandomizedcontrolledtrial‏ ‎‡A Induction therapy with bortezomib and dexamethasone followed by autologous stem cell transplantation versus autologous stem cell transplantation alone in the treatment of renal AL amyloidosis: a randomized controlled trial‏ ‎‡9 1‏
919 ‎‡a influenceofguidelineadherenceandparametercontrolontheclinicaloutcomesinpatientswithdiabeticnephropathy‏ ‎‡A Influence of guideline adherence and parameter control on the clinical outcomes in patients with diabetic nephropathy‏ ‎‡9 1‏
919 ‎‡a inhibitionofglycogensynthasekinase3βpreventsnsaidinducedacutekidneyinjury‏ ‎‡A Inhibition of glycogen synthase kinase-3β prevents NSAID-induced acute kidney injury.‏ ‎‡9 1‏
919 ‎‡a inhibitionofmirna21preventsfibrogenicactivationinpodocytesandtubularcellsiniganephropathy‏ ‎‡A Inhibition of miRNA-21 prevents fibrogenic activation in podocytes and tubular cells in IgA nephropathy‏ ‎‡9 1‏
919 ‎‡a initialtranscatheterthrombolysisforacutesuperiormesentericvenousthrombosis‏ ‎‡A Initial transcatheter thrombolysis for acute superior mesenteric venous thrombosis‏ ‎‡9 1‏
919 ‎‡a interleukin1receptorantagonistalleleisitageneticlinkbetweenhenochschonleinnephritisandiganephropathy‏ ‎‡A Interleukin-1 receptor antagonist allele: is it a genetic link between Henoch-Schönlein nephritis and IgA nephropathy?‏ ‎‡9 1‏
919 ‎‡a latedevelopingc4dpositivehumoralrenalallograftrejectionassociatedwithwithdrawalofmycophenolatemofetil‏ ‎‡A Late developing C4d-positive humoral renal allograft rejection associated with withdrawal of mycophenolate mofetil‏ ‎‡9 1‏
919 ‎‡a lipoproteinglomerulopathyclinicalfeaturesandpathologicalcharacteristicsinchinese‏ ‎‡A Lipoprotein glomerulopathy: clinical features and pathological characteristics in Chinese.‏ ‎‡9 1‏
919 ‎‡a longtermoutcomeandprognosticfactorsofidiopathicmembranousnephropathyinthechinesepopulation‏ ‎‡A Long-term outcome and prognostic factors of idiopathic membranous nephropathy in the Chinese population‏ ‎‡9 1‏
919 ‎‡a longtermoutcomeofchinesepatientswithmembranouslupusnephropathy‏ ‎‡A Long-term outcome of Chinese patients with membranous lupus nephropathy‏ ‎‡9 1‏
919 ‎‡a longtermoutcomeofiganephropathypatientswithrecurrentmacroscopichematuria‏ ‎‡A Long-term outcome of IgA nephropathy patients with recurrent macroscopic hematuria‏ ‎‡9 1‏
919 ‎‡a longtermoutcomeofiganephropathywithminimalchangediseaseacomparisonbetweenpatientswithandwithoutminimalchangedisease‏ ‎‡A Long-term outcome of IgA nephropathy with minimal change disease: a comparison between patients with and without minimal change disease‏ ‎‡9 1‏
919 ‎‡a longtermrenalsurvivalandrelatedriskfactorsinpatientswithiganephropathyresultsfromacohortof1155casesinachineseadultpopulation‏ ‎‡A Long-term renal survival and related risk factors in patients with IgA nephropathy: results from a cohort of 1155 cases in a Chinese adult population‏ ‎‡9 1‏
919 ‎‡a malignantperivascularepithelioidcelltumorpecomaofcervixwithtfe3generearrangementacasereport‏ ‎‡A Malignant perivascular epithelioid cell tumor (PEComa) of cervix with TFE3 gene rearrangement: a case report.‏ ‎‡9 1‏
919 ‎‡a melatoninapotentregulatorofhemeoxygenase1reducescardiopulmonarybypassinducedrenaldamageinrats‏ ‎‡A Melatonin, a potent regulator of hemeoxygenase-1, reduces cardiopulmonary bypass-induced renal damage in rats‏ ‎‡9 1‏
919 ‎‡a mercuryinducedmembranousnephropathyclinicalandpathologicalfeatures‏ ‎‡A Mercury-induced membranous nephropathy: clinical and pathological features‏ ‎‡9 1‏
919 ‎‡a mycophenolatemofetilvscyclophosphamidetherapyforpatientswithdiffuseproliferativelupusnephritis‏ ‎‡A Mycophenolate mofetil vs cyclophosphamide therapy for patients with diffuse proliferative lupus nephritis.‏ ‎‡9 1‏
919 ‎‡a nephrologyinchina‏ ‎‡A Nephrology in china‏ ‎‡9 1‏
919 ‎‡a nephroticproteinuriaandhypertension‏ ‎‡A Nephrotic proteinuria and hypertension‏ ‎‡9 1‏
919 ‎‡a nsfchealthresearchfundingandburdenofdiseaseinchina‏ ‎‡A NSFC health research funding and burden of disease in China‏ ‎‡9 1‏
919 ‎‡a obesityrelatedglomerulopathybodymassindexandproteinuria‏ ‎‡A Obesity-related glomerulopathy: body mass index and proteinuria‏ ‎‡9 1‏
919 ‎‡a obesityrelatedglomerulopathyinchinaacaseseriesof90patients‏ ‎‡A Obesity-related glomerulopathy in China: a case series of 90 patients‏ ‎‡9 1‏
919 ‎‡a obesityrelatedglomerulopathyinsightsfromgeneexpressionprofilesoftheglomeruliderivedfromrenalbiopsysamples‏ ‎‡A Obesity-related glomerulopathy: insights from gene expression profiles of the glomeruli derived from renal biopsy samples‏ ‎‡9 1‏
919 ‎‡a observationofefficacyandsafetyofconvertingthecalcineurininhibitortosirolimusinrenaltransplantrecipientswithchronicallograftnephropathy‏ ‎‡A Observation of efficacy and safety of converting the calcineurin inhibitor to sirolimus in renal transplant recipients with chronic allograft nephropathy‏ ‎‡9 1‏
919 ‎‡a peritonealdialysistreatmentforseverelupusnephritispatientscomplicatedwithessentialorgandysfunction‏ ‎‡A Peritoneal dialysis treatment for severe lupus nephritis patients complicated with essential organ dysfunction‏ ‎‡9 1‏
919 ‎‡a peritubularcapillaryc4ddepositioninlupusnephritisdifferentfromantibodymediatedrenalrejection‏ ‎‡A Peritubular capillary C4d deposition in lupus nephritis different from antibody-mediated renal rejection‏ ‎‡9 1‏
919 ‎‡a pickingtransplantglomerulopathyoutofthecanevidencefromaclinicopathologicalevaluation‏ ‎‡A Picking transplant glomerulopathy out of the CAN: evidence from a clinico-pathological evaluation‏ ‎‡9 1‏
919 ‎‡a podocyteautophagicactivityplaysaprotectiveroleinrenalinjuryanddelaystheprogressionofpodocytopathies‏ ‎‡A Podocyte autophagic activity plays a protective role in renal injury and delays the progression of podocytopathies‏ ‎‡9 1‏
919 ‎‡a podocytelesionsinpatientswithobesityrelatedglomerulopathy‏ ‎‡A Podocyte lesions in patients with obesity-related glomerulopathy‏ ‎‡9 1‏
919 ‎‡a podocyterepopulationbyrenalprogenitorcellsfollowingglucocorticoidstreatmentinexperimentalfsgs‏ ‎‡A Podocyte repopulation by renal progenitor cells following glucocorticoids treatment in experimental FSGS‏ ‎‡9 1‏
919 ‎‡a predictionofrenaloutcomesinpatientswithcrescenticlupusnephritis‏ ‎‡A Prediction of renal outcomes in patients with crescentic lupus nephritis.‏ ‎‡9 1‏
919 ‎‡a predominanceofintraglomerulartbetorgata3maydeterminemechanismoftransplantrejection‏ ‎‡A Predominance of intraglomerular T-bet or GATA3 may determine mechanism of transplant rejection‏ ‎‡9 1‏
919 ‎‡a presenceoffoamcellsinkidneyinterstitiumisassociatedwithprogressionofrenalinjuryinpatientswithglomerulardiseases‏ ‎‡A Presence of foam cells in kidney interstitium is associated with progression of renal injury in patients with glomerular diseases‏ ‎‡9 1‏
919 ‎‡a primaryfocalsegmentalglomerulosclerosisinnephroticpatientscommoncomplicationsandriskfactors‏ ‎‡A Primary focal segmental glomerulosclerosis in nephrotic patients: common complications and risk factors‏ ‎‡9 1‏
919 ‎‡a psfsfpqisaverycommongenefusionpartnerintfe3rearrangementassociatedperivascularepithelioidcelltumorspecomasandmelanoticxp11translocationrenalcancersclinicopathologicimmunohistochemicalandmolecularcharacteristicssugge‏ ‎‡A PSF/SFPQ is a very common gene fusion partner in TFE3 rearrangement-associated perivascular epithelioid cell tumors (PEComas) and melanotic Xp11 translocation renal cancers: clinicopathologic, immunohistochemical, and molecular characteristics sugge‏ ‎‡9 1‏
919 ‎‡a randomizedcontrolledtrialtoevaluateregionalcitrateanticoagulationpluslowdoseofdalteparinincontinuousvenovenoushemofiltration‏ ‎‡A Randomized Controlled Trial to Evaluate Regional Citrate Anticoagulation Plus Low-Dose of Dalteparin in Continuous Veno-Venous Hemofiltration.‏ ‎‡9 1‏
919 ‎‡a recurrentordenovoiganephropathywithcrescentformationafterrenaltransplantation‏ ‎‡A Recurrent or de novo IgA nephropathy with crescent formation after renal transplantation‏ ‎‡9 1‏
919 ‎‡a recurrentproliferativeglomerulonephritiswithmonoclonaliggdepositsafterarenaltransplantwhichwasinsensitivetopulsetherapyremittedbydoublefiltrationplasmapheresis‏ ‎‡A Recurrent Proliferative Glomerulonephritis With Monoclonal IgG Deposits After a Renal Transplant Which Was Insensitive to Pulse Therapy Remitted by Double Filtration Plasmapheresis‏ ‎‡9 1‏
919 ‎‡a regulationofmutyhadnarepairenzymeinrenalproximaltubularepithelialcells‏ ‎‡A Regulation of MUTYH, a DNA Repair Enzyme, in Renal Proximal Tubular Epithelial Cells‏ ‎‡9 1‏
919 ‎‡a relationshipbetweenserumsolubleurokinaseplasminogenactivatorreceptorlevelandsteroidresponsivenessinfsgs‏ ‎‡A Relationship between serum soluble urokinase plasminogen activator receptor level and steroid responsiveness in FSGS‏ ‎‡9 1‏
919 ‎‡a renalbiopsyintype2diabetestimingofcomplicationsandevaluatingofsafetyinchinesepatients‏ ‎‡A Renal biopsy in type 2 diabetes: timing of complications and evaluating of safety in Chinese patients‏ ‎‡9 1‏
919 ‎‡a renalhistologicchangesandtheoutcomeinpatientswithdiabeticnephropathy‏ ‎‡A Renal histologic changes and the outcome in patients with diabetic nephropathy‏ ‎‡9 1‏
919 ‎‡a renalinvolvementinnonhodgkinlymphomaprovenbyrenalbiopsy‏ ‎‡A Renal involvement in non-Hodgkin lymphoma: proven by renal biopsy‏ ‎‡9 1‏
919 ‎‡a rescuetherapybyimmunoadsorptionincombinationwithtacrolimusandmycophenolatemofetilforc4dpositiveacutehumoralrenalallograftrejection‏ ‎‡A Rescue therapy by immunoadsorption in combination with tacrolimus and mycophenolate mofetil for C4d-positive acute humoral renal allograft rejection‏ ‎‡9 1‏
919 ‎‡a retinoidsaugmenttheexpressionofpodocyteproteinsbyglomerularparietalepithelialcellsinexperimentalglomerulardisease‏ ‎‡A Retinoids augment the expression of podocyte proteins by glomerular parietal epithelial cells in experimental glomerular disease.‏ ‎‡9 1‏
919 ‎‡a reversalofactiveglomerularlesionsafterimmunosuppressivetherapyinpatientswithiganephropathyarepeatbiopsybasedobservation‏ ‎‡A Reversal of active glomerular lesions after immunosuppressive therapy in patients with IgA nephropathy: a repeat-biopsy based observation‏ ‎‡9 1‏
919 ‎‡a riskfactorsofvenousthromboembolisminfocalsegmentalglomerulosclerosiswithnephroticsyndrome‏ ‎‡A Risk factors of venous thromboembolism in focal segmental glomerulosclerosis with nephrotic syndrome‏ ‎‡9 1‏
919 ‎‡a roleofmyeloidderivedsuppressorcellsinglucocorticoidmediatedameliorationoffsgs‏ ‎‡A Role of Myeloid-Derived Suppressor Cells in Glucocorticoid-Mediated Amelioration of FSGS.‏ ‎‡9 1‏
919 ‎‡a rolesofmastcellsandmonocytechemoattractantprotein1intherenalinjuryofobesityrelatedglomerulopathy‏ ‎‡A Roles of mast cells and monocyte chemoattractant protein-1 in the renal injury of obesity-related glomerulopathy‏ ‎‡9 1‏
919 ‎‡a sarcopeniainpatientsundergoingmaintenancehemodialysisincidencerateriskfactorsanditseffectonsurvivalrisk‏ ‎‡A Sarcopenia in patients undergoing maintenance hemodialysis: incidence rate, risk factors and its effect on survival risk.‏ ‎‡9 1‏
919 ‎‡a significanceofantineutrophilcytoplasmicantibodiesinpatientswithpauciimmunecrescenticglomerulonephritis‏ ‎‡A Significance of anti-neutrophil cytoplasmic antibodies in patients with pauci-immune crescentic glomerulonephritis‏ ‎‡9 1‏
919 ‎‡a significanceofvascularendothelialgrowthfactorexpressioninrenaltissueofpatientswithpreeclampticnephropathy‏ ‎‡A Significance of vascular endothelial growth factor expression in renal tissue of patients with preeclamptic nephropathy‏ ‎‡9 1‏
919 ‎‡a successfulrenaltransplantationinapatientwithantineutrophilcytoplasmicautoantibodyassociatedmicroscopicpolyangiitiseffectofearlyplasmaexchangeandmycophenolatemofetil‏ ‎‡A Successful renal transplantation in a patient with antineutrophil cytoplasmic autoantibody-associated microscopic polyangiitis: effect of early plasma exchange and mycophenolate mofetil‏ ‎‡9 1‏
919 ‎‡a successfultreatmentofclassv+ivlupusnephritiswithmultitargettherapy‏ ‎‡A Successful treatment of class V+IV lupus nephritis with multitarget therapy.‏ ‎‡9 1‏
919 ‎‡a tacrolimuscombinedwithmycophenolatemofetilcaneffectivelyreversec4dpositivesteroidresistantacuterejectioninchineserenalallograftrecipients‏ ‎‡A Tacrolimus combined with mycophenolate mofetil can effectively reverse C4d-positive steroid-resistant acute rejection in Chinese renal allograft recipients‏ ‎‡9 1‏
919 ‎‡a applicationofurinaryproteomicsforthedetectionofbiomarkersofkidneydiseases‏ ‎‡A The application of urinary proteomics for the detection of biomarkers of kidney diseases.‏ ‎‡9 1‏
919 ‎‡a associationofageneticvariantinscaf8cnksr3withdiabetickidneydiseaseanddiabeticretinopathyinachinesepopulation‏ ‎‡A The Association of a Genetic Variant in SCAF8-CNKSR3 with Diabetic Kidney Disease and Diabetic Retinopathy in a Chinese Population.‏ ‎‡9 1‏
919 ‎‡a clinicalandpathologicalcharacteristicsofchinesepatientswithpauciimmunecrescentglomerulonephritis‏ ‎‡A The clinical and pathological characteristics of Chinese patients with pauci-immune crescent glomerulonephritis.‏ ‎‡9 1‏
919 ‎‡a clinicalcourseandlongtermoutcomeofprimaryfocalsegmentalglomerulosclerosisinchineseadults‏ ‎‡A The clinical course and long-term outcome of primary focal segmental glomerulosclerosis in Chinese adults‏ ‎‡9 1‏
919 ‎‡a clinicalfeaturesandoutcomesofsystemicalamyloidosisacohortof231chinesepatients‏ ‎‡A The clinical features and outcomes of systemic AL amyloidosis: a cohort of 231 Chinese patients‏ ‎‡9 1‏
919 ‎‡a evolutionofmorphologicalvariantsoffocalsegmentalglomerulosclerosisarepeatbiopsybasedobservation‏ ‎‡A The evolution of morphological variants of focal segmental glomerulosclerosis: a repeat biopsy-based observation.‏ ‎‡9 1‏
919 ‎‡a prevalenceofimmunologicinjuryinrenalallograftrecipientswithdenovoproteinuria‏ ‎‡A The prevalence of immunologic injury in renal allograft recipients with de novo proteinuria‏ ‎‡9 1‏
919 ‎‡a primaryglomerulonephritidesasystemsbiologyapproach‏ ‎‡A The primary glomerulonephritides: a systems biology approach‏ ‎‡9 1‏
919 ‎‡a prognosisofbiopsyprovenlupusnephritisinchinesepatientslongtermfollowupof86cases‏ ‎‡A The prognosis of biopsy-proven lupus nephritis in chinese patients: long term follow-up of 86 cases.‏ ‎‡9 1‏
919 ‎‡a relationshipbetweenbodyfatdistributionandrenaldamageinchinesewithobesity‏ ‎‡A The relationship between body fat distribution and renal damage in Chinese with obesity‏ ‎‡9 1‏
919 ‎‡a relationshipbetweenobesityanddiabeticnephropathyinchina‏ ‎‡A The relationship between obesity and diabetic nephropathy in China‏ ‎‡9 1‏
919 ‎‡a spectrumofbiopsyprovenkidneydiseasesinelderlychinesepatients‏ ‎‡A The spectrum of biopsy-proven kidney diseases in elderly Chinese patients‏ ‎‡9 1‏
919 ‎‡a treatmentofdiabeticnephropathywithtripterygiumwilfordiihookfextractaprospectiverandomizedcontrolledclinicaltrial‏ ‎‡A Treatment of diabetic nephropathy with Tripterygium wilfordii Hook F extract: a prospective, randomized, controlled clinical trial‏ ‎‡9 1‏
919 ‎‡a treatmentofearlymixedcellularandhumoralrenalallograftrejectionwithtacrolimusandmycophenolatemofetil‏ ‎‡A Treatment of early mixed cellular and humoral renal allograft rejection with tacrolimus and mycophenolate mofetil‏ ‎‡9 1‏
919 ‎‡a treatmentofsevereacuterenalfailurewithcontinuousrenalreplacementtherapy‏ ‎‡A [Treatment of severe acute renal failure with continuous renal replacement therapy]‏ ‎‡9 1‏
919 ‎‡a tripterygiumwilfordiihookfincreasethebloodconcentrationoftacrolimus‏ ‎‡A Tripterygium wilfordii hook f increase the blood concentration of tacrolimus‏ ‎‡9 1‏
919 ‎‡a triptolidereducesproteinuriainexperimentalmembranousnephropathyandprotectsagainstc5b9inducedpodocyteinjuryinvitro‏ ‎‡A Triptolide reduces proteinuria in experimental membranous nephropathy and protects against C5b-9-induced podocyte injury in vitro.‏ ‎‡9 1‏
919 ‎‡a typesof1000proteinandclinicopathologicalprofilesinpatientswithmonoclonalgammopathyofrenalsignificance‏ ‎‡A Types of M protein and clinicopathological profiles in patients with monoclonal gammopathy of renal significance‏ ‎‡9 1‏
919 ‎‡a usinganisolatedratkidneymodeltoidentifykidneyoriginproteinsinurine‏ ‎‡A Using an isolated rat kidney model to identify kidney origin proteins in urine‏ ‎‡9 1‏
919 ‎‡a vascularcalcificationburdenofchinesepatientswithchronickidneydiseasemethodologyofacohortstudy‏ ‎‡A Vascular calcification burden of Chinese patients with chronic kidney disease: methodology of a cohort study‏ ‎‡9 1‏
943 ‎‡a 202x‏ ‎‡A 2022‏ ‎‡9 1‏
943 ‎‡a 201x‏ ‎‡A 2010‏ ‎‡9 1‏
996 ‎‡2 DNB|1028577672‏
996 ‎‡2 BNF|14587111‏
996 ‎‡2 CYT|AC000652667‏
996 ‎‡2 KRNLK|KAC200609228‏
996 ‎‡2 DNB|1207107360‏
996 ‎‡2 CYT|AC000244289‏
996 ‎‡2 DNB|1258897334‏
996 ‎‡2 CYT|AC000396139‏
996 ‎‡2 DNB|1024526666‏
996 ‎‡2 CYT|AC000649886‏
996 ‎‡2 ISNI|0000000114521710‏
996 ‎‡2 SUDOC|261992333‏
996 ‎‡2 CYT|AC000655614‏
996 ‎‡2 BNF|14557401‏
996 ‎‡2 CYT|AC000649552‏
996 ‎‡2 BNF|16931997‏
996 ‎‡2 J9U|987007320990405171‏
996 ‎‡2 BNF|14598842‏
996 ‎‡2 BIBSYS|14032454‏
996 ‎‡2 DBC|87097968641284‏
996 ‎‡2 LC|n 2022037436‏
996 ‎‡2 NTA|146006003‏
996 ‎‡2 ISNI|0000000435100327‏
996 ‎‡2 SUDOC|200651552‏
996 ‎‡2 LC|n 89120553‏
996 ‎‡2 CAOONL|ncf10339399‏
996 ‎‡2 LC|n 96110068‏
996 ‎‡2 BNF|13736928‏
996 ‎‡2 DNB|1042585024‏
996 ‎‡2 DNB|1099117054‏
996 ‎‡2 ISNI|0000000083840371‏
996 ‎‡2 DNB|1223820742‏
996 ‎‡2 ISNI|0000000058763837‏
996 ‎‡2 ISNI|0000000427922080‏
996 ‎‡2 DNB|12304524X‏
996 ‎‡2 SUDOC|142546453‏
996 ‎‡2 PLWABN|9812417646405606‏
996 ‎‡2 SUDOC|125189613‏
996 ‎‡2 CYT|AC000659283‏
996 ‎‡2 CYT|AC000663205‏
996 ‎‡2 DNB|1014834791‏
996 ‎‡2 J9U|987007435369605171‏
996 ‎‡2 DNB|1067578617‏
996 ‎‡2 DNB|1189829916‏
996 ‎‡2 J9U|987007416049505171‏
996 ‎‡2 DNB|1059274248‏
996 ‎‡2 BNF|16526244‏
996 ‎‡2 PLWABN|9810660316905606‏
996 ‎‡2 NSK|000736752‏
996 ‎‡2 CAOONL|ncf12111514‏
996 ‎‡2 LC|nr 90015328‏
996 ‎‡2 J9U|987011561225405171‏
996 ‎‡2 CYT|AC000640467‏
996 ‎‡2 BNF|16203966‏
996 ‎‡2 BNF|14502055‏
996 ‎‡2 DNB|1142562506‏
996 ‎‡2 ISNI|0000000081162730‏
996 ‎‡2 NTA|364159774‏
996 ‎‡2 DNB|1077324782‏
996 ‎‡2 J9U|987007463167105171‏
996 ‎‡2 LIH|LNB:CUU_e_;=B_o_‏
996 ‎‡2 NSK|000679420‏
996 ‎‡2 ISNI|0000000117596670‏
996 ‎‡2 DNB|1237827515‏
996 ‎‡2 BNF|17175406‏
996 ‎‡2 SUDOC|164702997‏
996 ‎‡2 ISNI|0000000054883786‏
996 ‎‡2 SUDOC|147145597‏
996 ‎‡2 LC|n 84178440‏
996 ‎‡2 SUDOC|182607232‏
996 ‎‡2 RERO|A003525946‏
996 ‎‡2 RERO|A003525945‏
996 ‎‡2 ISNI|0000000385737601‏
996 ‎‡2 NDL|00726595‏
996 ‎‡2 NII|DA05170926‏
996 ‎‡2 BNF|17808804‏
996 ‎‡2 ISNI|0000000063438123‏
996 ‎‡2 NTA|15192287X‏
996 ‎‡2 NDL|00749395‏
996 ‎‡2 CYT|AC000549136‏
996 ‎‡2 LC|n 96103093‏
996 ‎‡2 BNF|14374013‏
996 ‎‡2 SUDOC|20451682X‏
996 ‎‡2 BIBSYS|5009996‏
996 ‎‡2 ISNI|000000036758244X‏
996 ‎‡2 CAOONL|ncf11927910‏
996 ‎‡2 J9U|987007423924405171‏
996 ‎‡2 NII|DA02887378‏
996 ‎‡2 CAOONL|ncf10107192‏
996 ‎‡2 ISNI|0000000079443015‏
996 ‎‡2 BNF|16018587‏
996 ‎‡2 ISNI|0000000075815846‏
996 ‎‡2 SUDOC|155274856‏
996 ‎‡2 ISNI|0000000080848300‏
996 ‎‡2 LC|n 81129639‏
996 ‎‡2 BIBSYS|1682591864191‏
996 ‎‡2 ISNI|0000000382528695‏
996 ‎‡2 ISNI|0000000063341858‏
996 ‎‡2 SUDOC|251323463‏
996 ‎‡2 ISNI|0000000079969826‏
996 ‎‡2 J9U|987007381683105171‏
996 ‎‡2 DNB|140370676‏
996 ‎‡2 LC|n 82081727‏
996 ‎‡2 CYT|AC000639386‏
996 ‎‡2 DNB|1257913131‏
996 ‎‡2 BNF|14603741‏
996 ‎‡2 CYT|AC000652704‏
996 ‎‡2 CYT|AC000647578‏
996 ‎‡2 BNF|15927877‏
996 ‎‡2 BIBSYS|90319714‏
996 ‎‡2 ISNI|0000000064113320‏
996 ‎‡2 ISNI|0000000357244172‏
996 ‎‡2 ISNI|0000000497230397‏
996 ‎‡2 NII|DA12292796‏
996 ‎‡2 LC|nr 95029419‏
996 ‎‡2 LC|no2021044959‏
996 ‎‡2 DNB|1154971082‏
996 ‎‡2 ISNI|0000000081723948‏
996 ‎‡2 ISNI|0000000495952353‏
996 ‎‡2 CAOONL|ncf10454067‏
996 ‎‡2 CYT|AC000650362‏
996 ‎‡2 DNB|1077379463‏
996 ‎‡2 ISNI|0000000116571471‏
996 ‎‡2 LC|n 00000582‏
996 ‎‡2 LC|no2012022170‏
996 ‎‡2 BIBSYS|1576136031517‏
996 ‎‡2 CYT|AC000632322‏
996 ‎‡2 NII|DA11288512‏
996 ‎‡2 CAOONL|ncf11533926‏
996 ‎‡2 ISNI|0000000055238885‏
996 ‎‡2 BNF|16988988‏
996 ‎‡2 NUKAT|n 2007122329‏
996 ‎‡2 DNB|171606663‏
996 ‎‡2 DNB|1042918341‏
996 ‎‡2 LC|nb2015014088‏
996 ‎‡2 DNB|122146646‏
996 ‎‡2 PLWABN|9810617160705606‏
996 ‎‡2 CYT|AC000207040‏
996 ‎‡2 SUDOC|183683102‏
996 ‎‡2 SUDOC|227344782‏
996 ‎‡2 NTA|213280876‏
996 ‎‡2 DNB|1282746022‏
996 ‎‡2 SUDOC|077603532‏
996 ‎‡2 CYT|AC000647874‏
996 ‎‡2 DNB|1117059278‏
996 ‎‡2 NSK|000593628‏
996 ‎‡2 NDL|00383643‏
996 ‎‡2 BNF|15989255‏
996 ‎‡2 DNB|1175679240‏
996 ‎‡2 DNB|116215232X‏
996 ‎‡2 DNB|136092780‏
996 ‎‡2 NYNYRILM|358262‏
996 ‎‡2 LC|no2009040736‏
996 ‎‡2 ISNI|0000000040695928‏
996 ‎‡2 CYT|AC000641914‏
996 ‎‡2 LC|no2009040738‏
996 ‎‡2 SELIBR|215036‏
996 ‎‡2 NTA|168294648‏
996 ‎‡2 DNB|1068664541‏
996 ‎‡2 ISNI|0000000002787987‏
996 ‎‡2 CYT|AC000663382‏
996 ‎‡2 LC|n 2017027353‏
996 ‎‡2 DNB|160018188‏
996 ‎‡2 DNB|1069073830‏
996 ‎‡2 ISNI|0000000031740627‏
996 ‎‡2 PLWABN|9811772647805606‏
996 ‎‡2 BNF|14529602‏
996 ‎‡2 ISNI|0000000475907539‏
996 ‎‡2 ISNI|000000008422671X‏
996 ‎‡2 LC|no2022068974‏
996 ‎‡2 SUDOC|166073113‏
996 ‎‡2 PLWABN|9810648479405606‏
996 ‎‡2 NSK|000206759‏
996 ‎‡2 LIH|LNB:V-111283;=BC‏
996 ‎‡2 SUDOC|179347519‏
996 ‎‡2 ISNI|0000000059890571‏
996 ‎‡2 BNF|15596356‏
996 ‎‡2 NKC|vut2011439967‏
996 ‎‡2 NII|DA04250101‏
996 ‎‡2 ISNI|000000006401412X‏
996 ‎‡2 NTA|364163917‏
996 ‎‡2 CYT|AC000647905‏
996 ‎‡2 CAOONL|ncf11889537‏
996 ‎‡2 CYT|AC000004624‏
996 ‎‡2 LC|n 2014181820‏
996 ‎‡2 BIBSYS|99029596‏
996 ‎‡2 BIBSYS|8014683‏
996 ‎‡2 CYT|AC000468479‏
996 ‎‡2 DNB|1080567224‏
997 ‎‡a 0 0 lived 0 0‏ ‎‡9 1‏